Background-Endothelial nitric oxide (NO)-mediated responses are impaired in arterioles of male spontaneously hypertensive rats (SHR), but they are still present in female SHR. We hypothesized that in vitro incubation of arterioles of male SHR with estrogen will restore NO-mediated responses by upregulation of endothelial NO synthase. Methods and Results-Responses to increases in perfusate flow (from 0 to 25 L/min) and to the calcium ionophore A23187 (5ϫ10 Ϫ8 to 10 Ϫ6 mol/L), norepinephrine (NE; 10 Ϫ7 to 3ϫ10 Ϫ7 mol/L), sodium nitroprusside (SNP; 10 Ϫ8 to 10
R ecent studies documented that estrogen contributes to the sex difference in the incidence of cardiovascular diseases. 1 These studies also suggested several mechanisms by which estrogen could evoke its beneficial cardiovascular effects. Increasing evidence suggests that upregulation of endothelial nitric oxide synthesis by the long-term presence of estrogen is one such possible mechanism. 1 The greater NO-mediated vascular responses in female normotensive 2 as well as hypertensive animals compared with their male counterparts indicates that estrogen potentiates endothelial function. 3 Estrogen replacement therapy significantly enhanced the acetylcholine-induced NO-mediated relaxation of the aorta of gonadectomized male spontaneously hypertensive rats (SHR). 4 Also, long-term treatment of cholesterol-fed rabbits with estrogen decreased atherosclerotic lesions significantly, which was paralleled by an improved NO-dependent endothelial function. 5 Moreover, estrogen replacement restored basal NO release in ovariectomized female rats with chronic heart failure. 6 In humans, a link between the plasma levels of estrogen and NO in perimenopausal and postmenopausal women 7, 8 was also demonstrated, whereas in preeclampsia with hypertension, a lower circulating estrogen level is associated with reduced release of NO. 9 Thus, a positive relationship between estrogen and basal or stimulated release of NO has been established in both large and small vessels, in vivo and in vitro. 10Ϫ14 One of the important local factors participating in the regulation of arteriolar tone is wall shear stress, which is the primary stimulus for the release of endothelial NO. 15, 16 An impaired dilation in response to increases in shear stress could play an important role in the increased arteriolar resistance in hypertension. 9, 17 Our previous studies demonstrated that NO-mediated dilations to agonists 18, 19 and flow/ shear stress 20, 21 are impaired in arterioles of male SHR. In contrast, in female SHR, arteriolar release of NO is still, in large part, preserved. 19, 22 The mechanism by which the long-term presence of estrogen in vivo improves endothelial function, as manifested by enhanced NO-mediated responses, is not yet identified. It remains of interest, therefore, to elucidate whether and to what extent these responses are a result of greater release of NO elicited by estrogen-induced upregulation of NO synthase or of other mechanisms, including the effects of estrogen on plasma lipid profile. 23 To exclude these possible in vivo effects of estrogen, we designed in vitro studies. We hypothesized that incubation of arterioles of male SHR with estrogen can restore NO-dependent responses. Thus, we conducted experiments in isolated cannulated and pressurized arterioles that were incubated with physiological concentrations of estrogen to reveal the direct effects of estrogen on endothelium-dependent, NO-mediated responses.
Methods

Experimental Setup
Experiments were conducted on single arterioles (Ϸ75 m in diameter) of gracilis muscle isolated from 12-week-old male SHR. Rats were anesthetized with an injection of sodium pentobarbital 50 mg/kg IP. The dissection and isolation procedure of arterioles has been described previously. 13 An Ϸ1-mm segment of an arteriole was isolated and cannulated with 2 glass pipettes in a vessel chamber and suffused (1 mL/min) with sterilized physiological salt solution containing 10
Ϫ5 mol/L L-arginine and 1% antibiotic-antimycotic (Gibco Laboratory) buffered with NaHCO 3 (24.0 mmol/L)/5% CO 2 plus ambient air to maintain pH at 7.4. The vessel chamber consisted of 2 parallel chambers that were perfused separately. Intravascular pressure and temperature were maintained at 80 mm Hg and 37°C, respectively. Intraluminal flow was established by changing proximal and distal pressures, controlled by 2 pressure-servo systems (Living Systems Inc), to an equal degree but in opposite directions without changing intravascular pressure. 16 The flow rate was measured by a microflowmeter (FL-300, Omega).
Method of Incubation
After control experiments, isolated arterioles were incubated with 17␤-estradiol (17␤-E 2 , 10 Ϫ9 mol/L) in a cannulated, pressurized (50 mm Hg), and perfused condition at 37°C for 16 to 18 hours. The double-pipette chamber allows incubation of 2 vessels simultaneously, but independently, with, eg, 17␤-E 2 and 17␤-E 2 plus ICI 182,780, a specific estrogen receptor antagonist. 24 
Experimental Protocols
Changes in diameter of arterioles in response to increases in perfusate flow or to agonists were assessed. Vessels were equilibrated at 80 mm Hg of perfusion pressure without flow for 1 hour to develop spontaneous tone. Then perfusate flow was increased from 0 to 25 L/min in 5-L/min steps. After the flow-diameter relationships were obtained, flow was stopped, and then responses to the calcium ionophore A23187 (5ϫ10
Ϫ6 mol/L), and adenosine (ADO, 10 Ϫ6 to 5ϫ10 Ϫ5 mol/L) were tested at 80 mm Hg perfusion pressure.
In the first protocol, arteriolar responses to flow and agonists were assessed in control and after incubation with 17␤-E 2 
10
Ϫ9 mol/L (see Method of Incubation). On the basis of our preliminary experiments, this concentration of estrogen has no direct effect on the vascular diameter. After the incubation period, the vessel was reequilibrated at 80 mm Hg for 1 hour, and agonist-and flow-induced responses were reassessed. In the second protocol, after incubation with 17␤-E 2 , the endothelium was removed to test whether the estrogenrelated alteration in responses is endothelium-dependent. In the third protocol, the magnitude of NO-mediated responses was assessed with N -nitro-L-arginine methyl ester (L-NAME, 10 Ϫ4 mol/L), an inhibitor of NO synthase. After incubation with 17␤-E 2 , L-NAME was administered for an additional 20 minutes before the experiment was repeated. In the fourth protocol, the role of estrogen receptors in the responses was tested by incubation of the vessel with 17␤-E 2 plus ICI 182,780 (10 Ϫ7 mol/L), an inhibitor of estrogen receptors. 24 In the fifth protocol, vessels were incubated with 17␤-E 2 in the presence of 5,6-dichloro-1-␤-D-ribofuranosylbenzimidazole (DRB, 10 Ϫ5 mol/L), a reversible RNA polymerase II inhibitor, to clarify the nature of the genomic response. 25 Next, we used 17␣-E 2 
Ϫ9 mol/L for incubation of the vessels to exclude nonspecific steroid effects. The possible involvement of inducible nitric oxide synthase (iNOS) in these responses was also studied with aminoguanidine 5ϫ10 Ϫ5 mol/L to inhibit iNOS. 26, 27 17␤-E 2 -incubated vessels were subjected to aminoguanidine for 20 minutes before the experiments.
At the conclusion of each experiment, the suffusate solution was changed to a Ca 2ϩ -free physiological salt solution with EGTA (1.0 mmol/L). The vessels were incubated for 10 minutes, and the passive diameter of arterioles was obtained at 80 mm Hg. ICI 182,780 was a gift from Zeneca Pharmaceutical, England. All other drugs were obtained from Sigma Chemical Co. Estrogens and A23187 were dissolved in DMSO and then diluted with distilled water. The highest concentration of DMSO in the chamber was 0.1% (vol/vol), which had no effect on vascular tone.
Statistics
Data are presented as meanϮSEM. Flow-induced responses were normalized to the passive diameters and expressed as percent change. Wall shear stress was calculated by the equation 4Q/r 3 , where is the viscosity of the perfusate (0.007 poise at 37°C), Q is the perfusate flow, and r is the vessel radius. Responses to agonists were expressed as change in diameter. Statistical analyses were done by 2-way ANOVA, followed by Tukey's post hoc test. A value of PϽ0.05 was considered significant.
Results
The active diameters of arterioles in control and after incubation with 17␤-E 2 were significantly different (72.8Ϯ3.3 and 79.8Ϯ2.9 m, respectively). The passive diameter of arterioles was 136.5Ϯ4.1 m. The arteriolar tone, expressed as percent of passive diameter, was also significantly different before and after incubation with 17␤-E 2 (52.9Ϯ1.3% versus 58.3Ϯ0.8%).
Figure 1 (top) shows the normalized diameter of arterioles in response to increases in perfusate flow in control conditions and after 16 to 18 hours of incubation with 17␤-E 2 . In control conditions, increases in flow (from 0 to 25 L/min) elicited increases in the diameter. After incubation with 17␤-E 2 , arteriolar dilations to flow were significantly enhanced at all flow rates (eg, by Ϸ89% increase at maximal flow rate; 79.8Ϯ2.9 versus 103.7Ϯ3.7 m). Also, the significant difference in the slope of flow-diameter curves indicates that after 17␤-E 2 incubation, arterioles of male SHR dilated significantly more to increases in flow. Calculated wall shear stress (bottom) indicates that the shear stress values were significantly higher in control conditions (maximum, 62Ϯ9.1 dyne/cm 2 ) than after 17␤-E 2 incubation (maximum, 32.5Ϯ4.2 dyne/cm 2 ). To test the role of the endothelium in the 17␤-E 2 -induced alteration, the endothelium was removed after incubation. In this condition, flow-induced dilation was completely eliminated (Figure 2, top) , confirming our hypothesis that the restored flow-induced dilation by 17␤-E 2 incubation is endothelium-dependent. Next, we investigated the roles of both endothelial NOS (eNOS) and iNOS in the restored flow-induced dilation by incubation with 17␤-E 2 . Figure 2 (middle) shows that L-NAME abolished the estrogen-induced improvement of NO mediation, whereas it was not affected by aminoguanidine (bottom), indicating that the improved flow-induced dilation is mediated by NO derived from eNOS.
To ascertain further that incubation with estrogen restores NO mediation, arteriolar responses to A23187, NE, SNP, and ADO were investigated (Figure 3) . In control conditions, A23187 elicited constriction of arterioles from male SHR, as we found previously. 18 This was converted to dilation after incubation with 17␤-E 2 , which also significantly attenuated constrictions to NE. Dilations to SNP, however, were reduced by incubation with 17␤-E 2 . Administration of L-NAME after 17␤-E 2 incubation not only prevented the dilations but also, compared with control, increased constrictor responses to A23187 as well as to NE. Dilator responses to SNP were affected only at the highest concentration. Arteriolar responses to ADO were not affected in any of the conditions studied.
The nonspecific steroid action of estrogen on improved flow-dependent dilation was excluded by the findings that responses of vessels incubated with 17␣-E 2 were not different from control (Figure 4, top) . To further determine whether estrogen receptors and gene transcription are required for the effects of 17␤-E 2 , in separate experiments, the action of 17␤-E 2 was assessed by use of ICI 182,780 and DRB to block estrogen receptors and gene transcription, respectively. As shown in Figure 4 , ICI 182,780 (middle) or DRB (bottom), incubated together with 17␤-E 2 , prevented the restoration of flow-induced dilation, suggesting that hormone receptors and gene transcription are required for the action of estrogen. Figure 5 shows the effects of DRB on control responses of arterioles to flow (top) and agonists (middle and bottom). The maintained arteriolar responses indicate that control responses were not significantly affected by 16 to 18 hours of DRB treatment.
Discussion
The salient findings of the present study are that incubation of skeletal muscle arterioles isolated from male SHR with physiological concentrations of 17␤-E 2 for 16 to 18 hours restored NO-mediated flow-and agonist-induced dilations. Furthermore, transcriptional upregulation of eNOS, mediated by estrogen receptors, is responsible for the observed changes.
Previous studies demonstrated that estrogen replacement therapy increases blood flow to various tissues by mechanisms that involve an enhanced synthesis of endothelial NO. 2, 28, 29 In vivo, an important stimulus for the release of NO is an increase in wall shear stress elicited by increases in perfusate flow. 15 , 16 Previously, we found a sex difference in Normalized diameter of gracilis muscle arterioles of SHR as a function of perfusate flow in control conditions and after removal of endothelium (top, nϭ8), after incubation with 17␤-E 2 plus L-NAME (10 Ϫ4 mol/L, middle, nϭ12), or 17␤-E 2 plus aminoguanidine (AG, 5ϫ10
Ϫ5 mol/L, bottom, nϭ8). *Significant differences from control. PD indicates passive diameter.
responses to flow/shear stress of rat arterioles due to an enhanced NO synthesis/activity, which was dependent on the presence of estrogen in females. 14, 22 It is likely that multiple mechanisms are involved in the estrogen-related potentiation of NO-mediated vascular responses in vivo. It was also reported that inhibition of superoxide production by estrogen results in an increased activity of NO without an enhancement of the gene expression and level of NOS protein. 30 Thus, it was of interest to better define the nature of the mechanism(s) by which estrogen affects NO release in the absence of other mechanisms that may also play a role in the estrogen-related vascular effects in vivo. Isolated arterioles of gracilis muscle of male SHR were chosen for the present study because previous studies demonstrated that the NO-mediated portion of flow-induced response is impaired in these vessels. 20, 21 We hypothesized that the impaired NO-mediated flowinduced responses in skeletal muscle arterioles of male SHR could be normalized by incubation of vessels with 17␤-E 2 via transcriptional upregulation of NO synthase. To the best of our knowledge, this is the first demonstration that a physiological concentration of estrogen in vitro can alter the reactivity of resistance vessels to shear stress and vasoactive agents.
Attenuated Arteriolar Tone After 17␤-E 2 Incubation
The basal tone of arterioles was different in control conditions and after incubation with 17␤-E 2 ( Figure 1) . The difference in arteriolar tone after 17␤-E 2 incubation was eliminated by removal of the endothelium or inhibition of NO synthesis by L-NAME (Figure 2 , top and middle), suggesting that a greater basal release of endothelial NO accounts for the reduced myogenic tone of arterioles incubated with estrogen. This finding agrees with previous studies of the effects of the in vivo presence of estrogen. 6Ϫ8, 13, 19 
Restored NO-Mediated Responses to Flow/Shear Stress and Agonists After Incubation With 17␤-E 2
Arterioles that had been exposed to 17␤-E 2 overnight exhibited a significantly augmented dilation in response to increases in flow compared with control responses, as shown by the significant leftward shift in the slope of the flow-diameter curves (Figure 1, top) . These responses were not altered by incubation with 17␣-E 2 ( Figure 4, top) , indicating a specific action of 17␤-E 2 on the vascular function. The physiological relevance of the enhanced flow-induced dilation is indicated further by the calculation of wall shear stress (Figure 1 , bottom). It shows a significant leftward shift of the shear stress-diameter curve after incubation with 17␤-E 2 , revealing that the value of shear stress required to dilate arterioles maximally is significantly less than in control. These findings support the idea that in hypertension, impairment of the regulation of shear stress in arterioles, because of a lesser release of endothelial NO, may contribute to the elevated peripheral resistance. 9, 17 Furthermore, because incubation with 17␤-E 2 restores the capacity of the endothelium to regulate shear stress, this mechanism may be responsible, at least in part, for the delayed onset and/or less severe development of hypertension in females.
Our previous studies showed that flow-dependent dilation of gracilis muscle arterioles, vessels that were also used in the present study, is mediated by endothelial NO and prostaglandins 16 and that in male SHR, the NO-mediated portion of the response is absent. 20, 21 In arterioles of female SHR, however, NO-mediated flow-induced dilation is retained. 22 To elucidate the endothelial nature of the improved flow-induced dilation after 17␤-E 2 incubation, the endothelium was removed and the effect of L-NAME on the responses was Figure 3 . Change in diameter of gracilis muscle arterioles of SHR in response to A23187 (nϭ11), NE (nϭ10), SNP (nϭ10), and ADO (nϭ7) in control conditions and after incubation with 17␤-E 2 (10 Ϫ9 mol/L), 17␤-E 2 plus L-NAME (10 Ϫ4 mol/L), and removal of endothelium (ECϪ). *Significant differences from control. investigated (Figure 2 ). Endothelium-denuded arterioles did not dilate to increases in flow (Figure 2 , top) after exposure to 17␤-E 2 . Also, L-NAME abolished the enhanced portion of the flow-induced response elicited by incubation with 17␤-E 2 ( Figure 2, middle) , indicating that incubation with 17␤-E 2 normalizes the impaired NO-mediated flow-induced dilation.
Recent studies showed that incubation of endotheliumdenuded rat aortas with 17␤-E 2 reduced vasoconstriction to phenylephrine via an upregulation of iNOS. 26 To assess the possible involvement of iNOS in the 17␤-E 2 incubationrelated responses, aminoguanidine 5ϫ10 Ϫ5 mol/L was administered to vessels after incubation with 17␤-E 2 . The concentration of aminoguanidine used inhibits iNOS-induced citrulline formation by Ϸ90% and nitrite formation by Ϸ60%, without significantly interfering with eNOS activity and the basal release of NO. 27 Figure 2 (bottom) shows that administration of aminoguanidine did not affect the flowdiameter curve of vessels incubated with 17␤-E 2 , indicating that iNOS is unlikely to have been involved in the enhanced responses to flow.
The effect of 17␤-E 2 incubation on arteriolar responses to vasoactive agents (Figure 3 ) adds further evidence to the restoration of NO synthesis by 17␤-E 2 . Previously, as in the present study, we found that hypertension not only impairs NO synthesis in arterioles of male SHR but also diverts prostaglandin synthesis from dilator to constrictor prostanoids (PGH 2 ), resulting in an endothelium-dependent constriction to A23187. 18 After incubation of arterioles with 17␤-E 2 , the dilation to A23187 is restored in an L-NAMEreversible manner, suggesting that increased production of NO after incubation with 17␤-E 2 outweighs the effect or prevents the production of PGH 2 in response to A23187. The attenuated constriction to NE after 17␤-E 2 incubation was eliminated by the presence of L-NAME, indicating a greater concomitant release of NO by estrogen. Dilator responses to SNP were significantly reduced after in vitro exposure to estrogen but were partially reversed by simultaneous administration of L-NAME. On the basis of previous findings, 31, 32 we speculate that a greater tonic release of NO due to incubation with estrogen lowers the sensitivity of vessels to nitrovasodilators. Although the mechanism for this remains unclear, a possible explanation may be related to a downregulation of guanylate cyclase or the cGMP-dependent protein kinase.
Mechanisms Responsible for the Restored NO-Mediated Responses by Incubation With 17␤-E 2
Estrogen-related enhanced NO mediation of vascular responses could be due to an altered transcriptional (genomic) and posttranscriptional regulation, cofactor or substrate availability, nongenomic effects, or other, as yet unidentified, factors. 1 Estrogen receptors have been identified to be present in endothelial cells, 33 and genomic regulation of endothelial function by estrogen has been shown to be estrogen receptordependent. 1, 33, 34 Activation of estrogen receptors affects an estrogen response element on the promoter of certain genes (such as eNOS) to initiate target gene expression. 35 We speculated that the restoration of the NO-mediated flowinduced response by 17␤-E 2 incubation is due to an upregulation of eNOS gene expression, followed by increased eNOS activity, providing for a greater NO release in response to increases in shear stress as well as vasoactive agents. To test this hypothesis, the vessels were incubated with 17␤-E 2 in the presence of ICI 182,780. We found that blockade of estrogen receptors prevented the restoration of NO-mediated dilations elicited by 17␤-E 2 ( Figure 4 , middle), suggesting that estrogen receptors play a crucial role in the responses. The presence of the transcription inhibitor DRB prevented the restoration of responses to estrogen (Figure 4, bottom) , suggesting that the effect of 17␤-E 2 in the present study is primarily transcriptionally based. DRB, in a concentration of 10 Ϫ5 mol/L, effectively inhibited the augmented (NOmediated) portion of the responses after 17␤-E 2 incubation (Figure 4 , bottom) yet did not affect the responses in control conditions ( Figure 5) . Thus, the experiments with ICI 182,780 and DRB suggest that the estrogen-related restoration of NO release to shear stress in arterioles of male SHR is a genomic effect, mediated via estrogen receptors. Moreover, the finding that 17␤-E 2 incubation improves NO mediation of vascular responses, regardless of whether NO release is elicited by shear stress or vasoactive agents, provides a convincing argument that 17␤-E 2 -induced transcriptional upregulation of eNOS accounts for the observed restoration of NO-mediated responses. Our conclusion is congruent with studies showing that estrogen upregulates eNOS gene expression in cultured endothelial cells 34 and that there is significantly reduced basal release of NO in aorta of estrogen receptor knockout mice. 36 Recently, a new mechanism regarding an acute estrogeninduced activation of eNOS has been reported. This activation is mediated by estrogen receptors but is nongenomic in nature, as indicated by the failure of actinomycin D or DRB to prevent the effect of estrogen. 37, 38 The potential mechanism causing the alteration is reported to be either dependent on 37 or independent of 38 cytosolic Ca 2ϩ , revealing a speciesor tissue-specific response to estrogen.
In summary, we found that incubation with physiological concentrations of estrogen normalizes the impaired dilator responses of skeletal muscle arterioles of male hypertensive rats to shear stress and vasoactive agents by an estrogen receptor-mediated, transcriptional upregulation of eNOS. The results may well form the basis of the mechanism by which estrogen protects against vascular injury and exerts its beneficial effect on the cardiovascular system.
